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Background: Smoking cessation is emerging as an important component in current HIV care to reduce
smoking-related adverse health outcomes. This study aimed to examine motivation to quit and its associated
factors in a sample of 409 HIV-positive smokers in Vietnam.
Methods: A cross-sectional survey was conducted from January to September 2013 in Hanoi (the capital) and Nam
Dinh (a rural city). Motivation to quit was measured by a 4-point single item, and was dichotomized as having any
motivation versus no motivation. Smoking history, nicotine dependence (Fagerstrom Test of Nicotine Dependence),
and other covariates were self-reported by participants. Multivariate logistic regression was performed to identify
correlates of motivation to quit.
Results: The sample was mostly male (97%). Mean age was 36 years (SD = 5.8). Approximately 37% and 69% of
the sample were hazardous drinkers and ever drug users, respectively. The mean duration of HIV infection and ART
treatment were 6 years (SD = 3.6) and 5 years (SD = 2.2), respectively. Overall, 59% of the sample was motivated to
quit. Factors significantly associated with motivation to quit were income, pain, currently taking Methadone, and
the interaction between binge drinking and lifetime drug use. Individuals with the highest income level (OR = 2.2,
95% CI = 1.3-3.6), moderate income level (OR = 1.8, 95% CI = 1.1-3.1), and currently feeling pain (OR = 1.6, 95%
CI = 1.0-2.5) were more likely to be motivated to quit. Conversely, taking Methadone was associated with a lower
likelihood of motivation to quit (OR = 0.4, 95% CI = 0.2-0.9). Also, those who reported binge drinking only (OR = 0.5,
95% CI = 0.3-0.9), lifetime drug use only (OR = 0.3, 95% CI = 0.1, 0.7), or both substance uses (OR = 0.4, 95% CI = 0.2,
0.8) were less motivated to quit smoking.
Conclusion: Smoking cessation treatment should be integrated into HIV care in Vietnam, and should be tailored
to meet specific needs for individuals with different attitudes on smoking, low income, and polysubstance use.
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Cigarette smoking among people living with HIV/AIDS
(PLWHA) represents a growing public health problem
[1,2]. The combination of high smoking prevalence and
prolonged survival among PLWHA places this vulnerable
group at an elevated risk of chronic smoking-related con-
ditions (e.g., cardiovascular diseases, non-AIDS cancers)
[1]. Therefore, efficacious smoking cessation treatment of-
fers the potential to reduce morbidity and mortality for* Correspondence: nhungnguyen.hup@gmail.com
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unless otherwise stated.PLWHA. Research indicates that smoking cessation
among HIV-positive smokers could decrease the risk of
overall mortality by 16%, the risk of cardiovascular dis-
eases by 20%, and the risk of non-AIDS malignancies by
34% [3]. Also, an increased time length of smoking ab-
stinence is associated with decreased HIV-related symp-
tom burden [4] and decreased risk of cardiovascular
diseases [5]. Collectively, smoking cessation is emerging
as an important component in current HIV care [6].
Available data indicate a mixed level of desire to quit
smoking among HIV-positive smokers, with approximately
37-75% thinking about quitting [7-11]. While many HIV-
positive smokers are interested in quitting and have madel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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reported that the abstinence rate among PLWHA was
nearly half the estimate for the general population [8]. The
overlap between HIV/AIDS, low socioeconomic status,
substance abuse, and mental illnesses may make smoking
abstinence more difficult among PLWHA as compared to
the general population [9,12]. To help PLWHA quit
successfully, predictors of smoking cessation should be
identified, and efforts to match HIV-positive smokers
with appropriate interventions should be evaluated. Ac-
cording to theories of health behavior change (e.g., the
Theory of Planned Behavior [13], the Transtheoretical
Model [14]), motivation to quit directly increases intention
to quit, facilitates cessation attempts, and increases success-
ful abstinence rates. However, motivated smokers may not
have the intention to quit due to barriers related to quitting.
Thus, cessation interventions are needed to increase readi-
ness to quit smoking and to promote abstinence [15]. To
design effective cessation interventions, a thorough under-
standing of motivation to quit is critical to explore facilita-
tors and barriers related to quitting, and to elucidate
teachable moments. To date, there is a paucity of research
on motivation to quit among HIV-positive smokers, espe-
cially in developing countries, where both smoking and
HIV epidemics have severe effects [16].
Viet Nam is a developing country confronting detri-
mental impacts from the intersection of cigarette smok-
ing and HIV/AIDS. The estimates of current cigarette
smoking in the general population were approximately
19.9%, higher in males (39.7%) than in females (1.2%)
[17]. Furthermore, smoking is considered as an accepted
behavior among men and accounts for 28% of all adult
male deaths [18]. The cost of three smoking-related
diseases (i.e., lung cancer, heart disease, and chronic ob-
structive pulmonary disease) was 77.5 million USD,
approximately 4.3% of the total healthcare expenditure
[19]. In addition to this smoking epidemic, Viet Nam re-
mains in a concentrated HIV epidemic, which is mainly
driven by drug users. The HIV prevalence among adults
ages 15–49 years is 0.45% with 282,787 PLWHA nation-
wide [20]. Vietnam is ranked fifth among twelve countries
with highest HIV burden in Asian and Pacific region [21].
Of note, our exploratory study observed a high smoking
rate (36.1%) and a low lifetime cessation rate (i.e., 20.9% of
ever smokers have successfully quit) in a sample of 1133
PLWHA in Vietnam [22] . Additionally, previous studies
revealed that approximately 70% of PLWHA use illicit
drugs [23] and 55% use alcohol [24] in Vietnam. Collect-
ively, engaging in other substances and cultural perspec-
tives may be unique barriers for quitting smoking among
HIV-positive smokers in this developing country. To our
knowledge, there has been no study about motivation to
quit among PLWHA in Vietnam. Therefore, this study
aimed to examine motivation to quit and its correlates ina sample of HIV-positive smokers. Findings from the
study may add to limited evidence on this issue in general,
and inform future cessation interventions targeting to
HIV-positive smokers in Vietnam in particular.
Methods
Study design and settings
A cross-sectional survey was conducted in Hanoi (the
capital) and Nam Dinh (a rural city) from January to
September 2013. These two cities are among the areas
with the largest HIV infection burden in the northern
region in Vietnam, with 20,762 and 3781 PLWHA in
Hanoi and Nam Dinh, respectively [20]. Five antiretroviral
therapy (ART) clinics in Hanoi and three ART clinics in
Nam Dinh were purposively selected based on the follow-
ing criteria: 1) including central, provincial, and district
level sites; 2) providing ART services; and 3) having a suf-
ficient number of HIV/AIDS patients.
Study subjects
Patients were approached and recruited through a con-
venience sampling technique. To be eligible, patients must
have been 18 years or older, HIV-positive, currently taking
ART, and willing to provide written informed consent. In-
dividuals having any serious health problems that could
interfere with participating in an interview were excluded
from the study. All eligible patients presenting at the
clinics during the study period were identified and invited
to participate in the survey until a sufficient sample size of
at least 100 patients per provincial or district site, and 200
patients per central site, was obtained. Participants were
asked to complete a 30–45 minute face-to-face interview.
Measures
Outcome variable
The primary outcome was motivation to quit smoking.
Based on the Contemplation Ladder [15], a common meas-
ure of readiness to quit smoking, we devised a single item
“Currently, what is your thinking about quitting smoking?”
to measure motivation to quit. Responses included “No
thought of quitting”, “Think I should quit but not quite
ready”, “Starting to think about how to change my smoking
patterns”, and “Take action to quit". The outcome was
dichotomized in data analyses. That is, participants who
chose “No thought of quitting” were considered as having
no motivation to quit. In contrast, those who chose the
remaining responses were categorized as having motivation
to quit. Additionally, motivated participants were asked
when they planned to quit smoking from the time of inter-
view, and what cessation supports they preferred.
Covariate variables
Smoking-related characteristics: Based on validated smok-
ing instruments used in previous studies [25,26], we also
Nguyen et al. BMC Public Health  (2015) 15:326 Page 3 of 9devised items to assess other smoking indicators (e.g., age
at smoking initiation, number of cigarettes smoked per
day). We employed the Fagerstrom Test for Nicotine De-
pendence (FTND), a well-validated instrument, to evalu-
ate the level of nicotine dependence [27]. This measure
included six items, yielding a total score of 0–10 with
higher scores indicating higher nicotine dependence [27].
Sociodemographic characteristics (i.e., age, gender, educa-
tional attainment, marital status, income, and employment
status) were obtained. The annual income was calculated
by summing up all sources of income during the last
12 month, and then stratified into three quantiles.
Other risk behaviors were queried, including alcohol
and illicit drug use. Alcohol consumption was measured
by the brief version of the Alcohol Use Disorders Identifi-
cation Test-Consumption (AUDIT-C), a screen for heavy
drinking and/or active alcohol abuse at healthcare clinics
[28]. This instrument includes three questions: 1) “How
often do you have a drink containing alcohol?”; 2) “How
many standard drinks containing alcohol do you have on
a typical day?”; and 3) “How often do you have six or more
drinks on one occasion?”. The response score for each
item ranged from 0 to 4, making the total score scale
range from 0 to 12. Higher scores indicated the higher
likelihood patients were at risk of alcohol dependence.
Threshold scores of 4 or above in men and 3 or above in
women were used to identify hazardous drinkers. In
addition, binge drinking is defined by any positive re-
sponse to the third question. The Vietnamese version of
AUDIT-C instrument has been validated in previous stud-
ies [24,29]. Illicit drug use was examined in terms of his-
tory of drug use, current drug use, duration of drug use,
type of drugs, and route of drug use [24]. Health-related
characteristics were self-reported, and included weight,
height, HIV-infection duration, current HIV stage, recent
CD4 cell count, and ART treatment duration. CD4 cell
count was defined as the number of CD4 cells per cubic
millimeter (mm3) of blood; this was dichotomized at the
cut point of 200 cells per mm3 of blood. Feeling pain and
anxiety were assessed by two items from the EQ-5D-5 L, a
measure of health-related quality of life for PLWHA [30].
Accordingly, patients who answered “Slightly” to “Ex-
tremely” were considered as currently having pain or
anxiety. The Vietnamese version of EQ-5D-5 L instru-
ment has been validated in a previous study [31].
Data analyses
Descriptive statistics were conducted to compare socio-
demographic characteristics, substance use behaviors,
and health-related characteristics by level of motivation
to quit (Having motivation to quit vs. No motivation to
quit). Student´s t-test and Mann–Whitney U-test were
computed to examine differences between means of nor-
mally and non-normally distributed variables, respectively.Chi-square tests were used for categorical variables. Fre-
quencies and distributions of smoking-related items by
level of motivation to quit were also described. Multiple
logistic regression modeling was performed to identify
factors significantly associated with motivation to quit.
Models were built based on the strategy recommended by
Hosmer & Lemeshow [32]. Accordingly, variables whose
univariate tests had a p-value <0.25 were candidates for
the multivariate model (i.e., income, marital status, em-
ployment status, CD4 cell count, feeling pain and anxiety,
currently taking Methadone) along with all variables of
known clinical importance (i.e., binge drinking, ever used
drugs). We then applied a stepwise backward model ap-
proach based on the log-likelihood ratio test including
variables with a p-value < 0.1. Collinearity was checked by
variance inflation factors with a cut off value of 10. All
potential interactions were examined. We assessed model
calibration using Hosmer-Lemeshow goodness-of-fit test
[32]. All tests of hypotheses were two-tailed with a sig-
nificance level of α less than 0.05. Statistical analyses
were performed with STATA version 12.0 (StataCorp
LP, College Station, Texas, USA).Ethical issues
The use of data for this analysis was approved by the
Vietnam Authority of HIV/AIDS Control's Scientific Re-
search Committee and the Institutional Review Board at
The University of Texas Health Science Center at Houston.Results
Sample characteristics
In total, 1258 patients were identified and invited to
participate in the survey. Of these, 1133 PLWHA were
surveyed (response rate 90%) and 409 current smokers
were identified and included in this data analysis. The
study sample was predominately male (97%) and had a
mean age of 36 years (SD = 5.8). The majority was from
Hanoi (87%), lived with a spouse/partner (67%), had less
than a high school education (56%), and was currently
working (76%). The mean AUDIT-C score was 2.9 (SD =
2.9). Approximately 37% and 43% of the sample were haz-
ardous drinkers and binge drinkers, respectively. More
than two thirds of the sample (69%) reported ever using
illicit drugs. Nevertheless, only 5 % were current drug
users, and 6% were in Methadone maintenance treatment.
Most participants (75%) had a recent CD4 count of 200 or
more cells/mm3, and 83% reported having normal weight.
Approximately 14% of participants were diagnosed with
AIDS. The mean duration of HIV infection and ART
treatment were 6 years (SD = 3.6) and 5 years (SD = 2.2),
respectively. Pain (34%) and anxiety (41%) were prevalent
in the study sample (Table 1).
Table 1 Characteristics of study participants (n = 409)
Characteristics Total Motivated to quit p-value
Yes (n = 243, 59%) No (n = 166, 41%)
Sociodemographics, % (n)
Age in years, mean (sd) 36.05 (5.8) 36.08 (5.8) 36.0 (5.7) 0.89
Gender
Female 3 (12) 3 (6) 4 (6) 0.50
Male 97 (397) 88 (237) 96 (160)
Annual income
Lowest (<1.2 million VND) 34 (139) 29 (70) 42 (69) 0.01
Moderate (1.2-3.0 million VND) 35 (142) 40 (96) 28 (46)
Highest (>3.0 million VND) 30 (124) 31 (76) 29 (48)
Marital status
Live with spouse/partner 67 (273) 69 (168) 63 (105) 0.22
Education
Less than high school 56 (230) 56 (136) 57 (94) 0.64
High school 35 (143) 34 (83) 36 (60)
More than high school 9 (36) 10 (24) 7 (12)
Location
Hanoi 87 (354) 86 (210) 87 (144) 0.92
Nam Dinh 13 (55) 14 (33) 13 (22)
Employment status
Currently working 76 (309) 81(196) 68 (113) <0.01
Substance use, % (n)
AUDIT-C score, mean (sd) 2.9 (2.9) 2.7 (2.8) 3.1 (3.0) 0.17
Hazard drinking 37 (151) 35 (85) 40 (66) 0.33
Binge drinking 43 (177) 39 (94) 50 (83) 0.02
Lifetime drug use 69 (282) 65 (159) 74 (123) 0.06
Current drug use 5 (20) 3 (8) 7 (12) 0.07
Currently taking Methadone 6 (25) 4 (10) 9 (15) 0.04
Health-related characteristics, % (n)
Recent CD4≥ 200 cells per mm3 75 (236) 71 (130) 81 (106) 0.046
BMI
Under weight (<18.5 kg/m2) 9 (36) 10 (24) 7 (12) 0.64
Normal weight (18.5-22.9 kg/m2) 83 (338) 82 (199) 84 (139)
Over weight (> = 23 kg/m2) 8 (35) 8 (20) 9 (15)
HIV stage
Without symptom 36 (149) 50 (85) 56 (64) 0.37
With symptom 20 (80) 31 (53) 24 (27)
AIDS 14 (56) 19 (32) 21 (24)
HIV duration (years), mean (sd) 6.1 (3.6) 6.0 (3.5) 6.3 (3.8) 0.46
ART duration (years), mean (sd) 4.5 (2.2) 4.4 (2.1) 4.5 (2.2) 0.71
Currently feeling pain 34 (138) 37 (90) 29 (48) 0.09
Currently feeling anxiety 41 (168) 44 (106) 37 (62) 0.21
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Smoking-related characteristics are presented in Table 2.
The mean age of smoking initiation was 17 years (SD =
4.1), corresponding to an average duration of smoking of
13 years (SD = 8.1). The mean Fagerstrom score was 3.6
(SD = 2.1), with 34% at very low dependence, 33% at low
dependence, 12% at moderate dependence, 15% at high
dependence, and 5% at very high dependence. Overall,
59% of the sample was motivated to quit, and 33% had
made at least one quit attempt in the past year. Among
motivated smokers, 24% and 42% planned to quit withinTable 2 Smoking-related characteristics of study participants
Smoking-related characteristics Total
Age at smoking initiation, mean (sd) 17.0 (4.1)





Duration of regular smoking in years, mean (sd) 13.3 (8.1)
Smoke within 5 min of waking, % (n) 27 (109)
FTND score, mean (sd) 3.6 (2.1)
Nicotine dependence level, % (n)




Very high 5 (21)
Quit attempts within the last 12 months, % (n) 33 (135)
Plan to quit, % (n)
Within 30 days (1 month)
1 to 3 months from now
3 to 6 months from now NA
6 to 12 months from now
1 or more years from now
Don’t know








Self-helpthe next month and the next 1–3 months at the time of
interview, respectively. Regarding types of cessation sup-
port, self-help was the most frequently endorsed method
selected (39%).
Factors associated with motivation to quit
Few differences were apparent between motivated and
non-motivated HIV-positive smokers. Participants who
were motivated to quit were more likely to make quit
attempts in the past year (50%), had a higher income,
and were currently working. Conversely, non-motivatedMotivated to quit p-value
Yes (n = 243) No (n = 166)
17.2 (3.8) 16.8 (4.4) 0.38
63 (152) 59 (98)
33 (79) 37 (62) 0.84
2 (4) 1 (2)
1 (3) 1 (2)
13.2 (7.9) 12.5 (8.6) 0.79
25 (61) 29 (48) 0.54
3.6 (2.1) 3.8 (2.2) 0.38
34 (82) 35 (58)
35 (84) 31 (52)
14 (34) 10 (16) 0.40
14 (33) 18 (29)
4 (10) 7 (11)
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taking Methadone, and had a CD4 count of 200 or more
cells/mm3 (Table 1).
Results from the multivariate logistic regression are
presented in Table 3. In the univariate analyses, factors
significantly related to motivation to quit were income,
employment status, binge drinking, CD4 cell count, and
the interaction between binge drinking and lifetime drug
use (data not shown). After adjusting for other covariates,
those retained in the multiple regression model were
income, the interaction between binge drinking and life-
time drug use, taking Methadone, and pain. Compared to
smokers with the lowest income level, those with the high-
est level (OR = 2.2, 95% CI = 1.3-3.6) and the moderate
level (OR = 1.8, 95% CI = 1.1-3.1) had a higher likelihood
of being motivated to quit. Similarly, individuals who cur-
rently had pain (OR = 1.6, 95% CI = 1.0-2.5) were more
likely to be motivated to quit. Lifetime drug use alone was
not a significant predictor. Rather this factor interacted
with alcohol consumption to reduce the likelihood of quit
motivation. Accordingly, smokers who reported binge
drinking only (OR = 0.5, 95% CI = 0.3-0.9), lifetime drug
use only (OR = 0.3, 95% CI = 0.1, 0.7), or both substance
uses (OR = 0.4, 95% CI = 0.2, 0.8) were less motivated to
quit compared to those who never used drugs and did not
binge drink. Of interest, participants who were currently
taking Methadone were less likely to be motivated to
quit, compared to those who were not taking Metha-








Moderate 2.20 (1.33-3.62) <0.01
Highest 1.84 (1.09-3.10) 0.02
Substance use
Interaction between alcohol and
drug use
Never use drugs + No binge
drinking
1.00
Binge drinking only 0.47 (0.25-0.89) 0.02
Lifetime drug use only 0.31 (0.14-0.67) <0.01







Currently feeling pain (Yes vs. No) 1.60 (1.02-2.52) 0.04Discussion
To our knowledge, the current study is among the
first to address motivation to quit smoking cigarettes
among PLWHA in Vietnam. Results revealed that a
substantial proportion of HIV-positive smokers were
motivated to quit (59.4%) in this developing country.
Although the estimate was lower than that in the
Vietnamese general population (67.5%) [17], it was in an
upper bound of a range reported among HIV-positive
cohorts worldwide [7-10,33,34].
While our motivation to quit rate is encouraging, we
observed a large discrepancy in attempting to quit by level
of quit motivation. That is, among motivated individuals,
more than half (50.2%) had made at least one quit attempt
in the past year and two thirds (66.3%) planned to quit in
the next 3 months. On the other hand, very few non-
motivated smokers (7.8%) reported attempting to quit in
the past year. These findings are congruent with the con-
ceptual framework proposed by Vidrine et al. [35] in which
smoking attitudes influence changes in smoking behavior.
Also, previous research indicates that motivation to quit
is positively associated with a number of quit attempts
[36,37] and successful abstinence [11,38]. Therefore,
motivated smokers are the best candidates for cessation
interventions, and should be targeted with evidence-based
treatments to increase quit rates [39,40]. For those not in-
terested in quitting, motivational enhancement and/or
psychoeducational approaches may be needed to change
beliefs and attitudes related to smoking, and to increase
quit motivation before providing more traditional cessa-
tion treatment [40]. Taken together, cessation treatment
efficacy could be improved through tailoring based on an
individual’s attitudes about smoking, including level of
quit motivation.
This study extends the evidence base in the literature
by identifying facilitators and barriers for motivation to
quit among HIV-positive smokers in a developing coun-
try. We found that higher income and pain were posi-
tively associated with quit motivation. This is consistent
with earlier reports that have identified economical dis-
advantages (i.e., low income) as predictors of poor cessa-
tion outcomes among HIV-positive smokers [41,42]. It is
likely that participants with low income have limited re-
sources for, and limited access to cessation treatment, com-
pared to higher income individuals [40]. Even the average
annual income per capita of our sample (US$132/year) was
much lower than that in the Vietnamese general popula-
tion (US$1730) [43], the socioeconomics disadvantages
continue to present among this low-income group. There-
fore, providing free cessation treatment may encourage
quitting smoking in this underserved group.
Additionally, we observed that HIV-positive smokers
currently having pain were more likely to be motivated
to quit. There is inconsistent evidence regarding the
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search suggests that smoking may help PLWHA to cope
with pain [36,44]. Therefore, pain may be a barrier to quit-
ting. In contrast, pain could be a facilitator for smoking
abstinence. Other research, such as Vidrine et al.’s frame-
work [35], indicates that smokers with higher perceived
impact of an HIV-related event (i.e., pain, or symptom
burden) may be more likely to change their attitudes on
smoking. Future research should fully elucidate this
association.
Variables associated with being unmotivated to quit
smoking included codependence with other substances.
In line with prior research [36,39,41], we did observe
that HIV-positive smokers with alcohol and/or drug use
were less motivated to quit. These major barriers for
smoking cessation are not especially unique to HIV-
positive populations, but rather also observed among other
populations [44]. A possible explanation is that smoking
and other substance use may be reciprocally reinforced be-
haviors due to the shared neurobiological mechanisms (i.e.,
common genetic factors, the dopaminergic neurotrans-
mission) [45] and the similar psychological and physical
cues and withdrawal symptoms (e.g., craving, stress)
[46]. Therefore, intensive cessation interventions, such
as multifaceted behavioral approaches combined with
pharmacotherapy to diminish withdrawal symptoms,
may be a potential strategy for this high risk group [44].
More evidence is warranted regarding the development
of appropriate cessation interventions for HIV-positive
smokers with polysubstance use within the context of
limited resources at HIV clinics.
Interestingly, this study found that HIV-positive smokers
who were taking Methadone were less motivated to quit
smoking. We are unaware of any research on potential im-
pacts of concurrent treatment for illicit drugs and nicotine
dependence among PLWHA. However, there is debate on
providing interventions on multiple health behaviors sim-
ultaneously or sequentially in the general population [47].
The main arguments being that cigarette is a less harmful
alternative to illicit drug, and that quitting smoking might
result in a negative impact on drug use treatment, mean
that smoking cessation interventions are often not pro-
vided for smokers in drug addiction treatment [48]. Never-
theless, a meta-analysis suggested that smoking cessation
interventions provided during other addiction treatment
interventions were associated with a 25% increased like-
lihood of long-term abstinence from alcohol and illicit
drugs, and also effected short-term smoking abstinence
[49]. Similarly, results from a randomized trial of 538
stimulant-dependent smokers demonstrated that con-
current smoking cessation and drug use treatment can
significantly improve smoking abstinence outcomes with-
out negatively impacting non-nicotine outcomes [50].
Additional research is necessary to address this issue,especially to identify teachable moments among HIV-
positive smokers with dual dependence.
The poor understanding of available treatments com-
bined with financial constraints may contribute to our
finding that self-help was the most preferred method to
quit smoking. This underscores a need to inform smokers
about the effectiveness of available smoking cessation
treatments. Current U.S. guidelines recommend a com-
bination of counseling and pharmacologic interventions
as traditional treatment for general smokers [40]. Smoking
cessation efforts targeting PLWHA in Vietnam particu-
larly need to be tailored to meet both the unique charac-
teristics of the HIV-positive population and the specific
circumstances in resource-limited settings. Frequent med-
ical visits to monitor disease progress and ART treatment
provide good opportunities to integrate smoking cessation
treatment into HIV care [44]. Additionally, a study in
Vietnam found that brief physician advice was very cost-
effective and should be included in the priority list of to-
bacco control policies [51]. As a first step, pilot research
should be conducted to test the feasibility and preliminary
efficacy of brief provider-delivered advice to quit smoking
at ART clinics in Vietnam. Such an effort would likely re-
quire substantial provider training and education efforts.
Specifically, recent findings in Vietnam revealed that less
than one third of general smokers (29.7%) receive advice
from healthcare staff to quit smoking [17].
The strengths of our study include a large sample of
HIV-positive smokers in Vietnam. Furthermore, our study
settings included both rural and urban areas, and selected
clinic sites encompassed ART clinics across all three levels
of the health system (i.e. central, provincial, and district
clinics). Importantly, validated measures (e.g., FTND,
AUDIT-C) used in this study make our findings more
reliable and comparable. However, several limitations
should also be considered. First, due to the nature of a
cross-sectional design, we cannot establish temporal or
causal relationships between independent variables and
motivation to quit. Second, self-reported data in this study
may be compromised by some degree of recall errors and
socially desirable responding. Third, the generalization of
our study results is limited by the convenience sampling
strategy. Fourth, the current study did not collect data on
psychosocial factors (e.g., self-efficacy, and perceived risk);
thus, other salient smoking-related constructs may under-
lie the observed findings. Assessing impacts of these factors
on motivation to quit is critical to have a better under-
standing of the mechanism of changing smoking behavior.
Finally, motivation to quit was dichotomized in our study
instead of using a continuum measure of the Contempla-
tion ladder. Therefore, motivation to quit smoking may
not have been measured in full, such as low motivation
versus high motivation. Future studies are needed to gain
insight into this issue.
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Given the high level of motivation to quit among HIV-
positive smokers in Vietnam, smoking cessation should
be integrated into HIV care to help smokers achieve suc-
cessful abstinence, and consequently to reduce adverse
health outcomes among PLWHA. Interventions tailored
to meet specific needs for individuals with different atti-
tudes on smoking, low income, and polysubstance use
may be warranted.
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